Archit Organosys Share Price

Archit Organosys Limited, with its registered office in Ahmedabad, Gujarat, functions as a specialty chemicals manufacturing company in India. The company was founded in 1989 and was formerly known as Shri Chlochem Limited, changing its name to Archit Organosys Limited in May 2012. Archit Organosys manufactures and trades in chemical products including monochloroacetic acid (MCA), sodium monochloroacetate (SMCA), chloroacetyl chloride, trichloroacetyl chloride (TCAC), and organic chemicals, pigments, and specialty derivatives under the AOL brand. The company’s products are used in the synthesis of agricultural chemicals, cosmetic surfactants, oil drilling chemicals, plastic additives, and adhesives and sealants. 

Archit Organosys share price on NSE and BSE indicates how market participants react to the company’s operational performance and the overall developments in the specialty chemicals sector. The company’s financial health depends on production volumes, raw material costs including acetic acid and chlorine, capacity utilization rates, export demand, and the performance of its chemical product segments. Archit Organosys stock price is influenced by various factors such as earnings, changes in raw material prices, regulatory changes in the chemical industry, and global demand for specialty chemicals. In the longer run, strategies such as expanding product portfolio, diversifying into new chemical categories, and increasing export penetration affect the stock market sentiments. All these factors need to be monitored closely to have an idea about the company’s stock price movements. 

Archit Organosys live share price provides real‑time information about the last price traded, bid and ask prices, and volume traded. These indicators represent market activity and liquidity, reflecting investor response to corporate announcements, economic conditions, and sector news. Constant monitoring of Archit Organosys live price helps in observing short‑term price volatility and shows how a stock moves relative to the broader specialty chemicals index. Furthermore, tracking Archit Organosys stock price movements helps investors understand real‑time market sentiment, price fluctuations, and trading behaviour. It allows them to evaluate short‑term performance, and respond to news, quarterly results, or sector trends that may influence the company’s valuation and overall investment outlook. 

Archit Organosys Limited Company Fundamentals 

A. Company Background

Archit Organosys Limited was founded in 1989 and is based in Ahmedabad, India. The company was formerly known as Shri Chlochem Limited and changed its name to Archit Organosys Limited in May 2012. The company is engaged in the manufacturing and trading of various chemical products, including monochloroacetic acid (MCA), sodium monochloroacetate (SMCA), chloroacetyl chloride, trichloroacetyl chloride (TCAC), organic chemicals, pigments, and specialty derivatives. The company markets its products under the AOL brand. The company’s products find applications in the synthesis of agricultural chemicals, cosmetic surfactants, oil drilling chemicals, plastic additives, and adhesives and sealants. Its manufacturing operations are based in India, with corporate functions managed from its registered office in Ahmedabad, Gujarat. Over time, the company has expanded its product portfolio and manufacturing capabilities. Financial performance is assessed through standard metrics such as revenue growth, operating margins, and capacity utilization. Market valuation indicators such as the P/E ratio are used by analysts for comparative assessment within the specialty chemicals sector. Overall fundamentals are influenced by raw material availability, demand cycles in downstream industries, and input cost fluctuations.

B. Company Product Lines

• Monochloroacetic Acid (MCA): Manufactures monochloroacetic acid used in the synthesis of various agricultural chemicals, cosmetic surfactants, and other products. 

• Sodium Monochloroacetate (SMCA): Produces sodium monochloroacetate for industrial applications. 

• Chloroacetyl Chloride and TCAC: Supplies chloroacetyl chloride and trichloroacetyl chloride for specialty chemical applications. 

• Other Chemicals: Offers organic chemicals, pigments, and specialty derivatives under the AOL brand. 

C. Company Revenue Model

• Domestic Chemical Sales: Revenue generated through sale of MCA, SMCA, and other chemical products to industrial customers across India. 

• Export Sales: Contribution from international customers in select global markets for specialty chemicals. 

• Contract Manufacturing: Income from custom manufacturing of chemical intermediates for other companies. 

• Other Operating Income: Revenue from ancillary activities. 

D. Geographic Presence

• Registered Office: Ahmedabad, Gujarat, India 

• Manufacturing Facilities: Production plants located in Gujarat region 

• Distribution Network: Domestic distribution across India through direct sales to industrial customers 

• Export Markets: Products supplied to select international markets 

E. Key Milestones

• 1989: Founding of Archit Organosys Limited (as Shri Chlochem Limited). 

• 2012: Name change to Archit Organosys Limited in May. 

• Recent years: Continued focus on specialty chemical manufacturing. 

F. Industry Perspective

The specialty chemicals industry is capital‑intensive and closely linked to demand from agriculture, personal care, oil drilling, plastics, and adhesives sectors. Demand trends are influenced by economic activity, industrial production, and growth in downstream manufacturing sectors. The industry also faces fluctuations in raw material prices such as acetic acid and chlorine, along with energy and logistics costs. Environmental regulations and sustainability requirements increasingly shape production practices. Companies in the sector must manage cyclical demand patterns and cost volatility while maintaining operational efficiency. These factors collectively influence financial performance and investor perception of firms like Archit Organosys within the broader specialty chemicals ecosystem.

Archit Organosys Stock Market Presence: Listings & Index Representation 

Archit Organosys Limited is listed on the National Stock Exchange under the symbol ARCHITORG and on the Bombay Stock Exchange with the scrip code 524640. Archit Organosys share price is actively traded on both exchanges. The company’s market presence is within the small‑cap segment of the market, having a market capitalization of approximately ₹96 crore. Due to its size and sector focus, Archit Organosys stock price is generally tracked by investors interested in the specialty chemicals industry. 

Archit Organosys Limited is part of several broad‑based and sector‑specific stock market indices, reflecting its position as a small‑cap specialty chemicals company in India. While it is not included in benchmark indices like the Sensex or Nifty 50, it is a constituent of wider market indices such as the BSE SmallCap and BSE Chemicals indices. Archit Organosys share price finds representation in these indices based on its market standing. This presence helps investors track the stock relative to other specialty chemical companies. 

Archit Organosys Limited Stock Performance and Share Price History 

Archit Organosys share price on the NSE reflects its position as a manufacturer of monochloroacetic acid and other specialty chemicals in India. Its performance is qualitatively driven by factors such as production capacity utilization, management of raw material costs including acetic acid and chlorine, growth in export sales, and the ability to control operational expenses. Investors compare the stock’s current movement with other specialty chemicals companies to assess relative strength within the sector. 

These underlying factors become visible through real market movements across different time periods. Similar trends appear during earnings‑driven price changes. Broader sector strength has also supported the stock. Beyond operational and sector influences, corporate actions such as product portfolio expansion can significantly affect share price movements by shaping future growth expectations. This shows how strategic initiatives may trigger short‑term swings, even within a regulatory environment influenced by environmental norms and import competition. 

While short‑term movements respond to events and announcements, longer‑term valuation trends are better captured by the stock’s annual high and low levels, offering context beyond daily or weekly changes. A notable peak indicates stronger demand for specialty chemicals and stable margins, whereas a significant low aligns with market corrections or sector volatility. These extremes reflect the impact of trade policies, global raw material price trends, and earnings visibility, providing a framework for understanding historical performance. 

Archit Organosys stock behavior mirrors the trading patterns of a small‑cap specialty chemicals company within India’s industrial manufacturing ecosystem. The company’s diversified portfolio spanning MCA, SMCA, and other specialty derivatives has shaped its price history. Over the past several months, the stock has experienced periods of sharp gains followed by phases of consolidation. For instance, it delivered positive returns in certain periods but recorded negative returns in other intervals, with the 52‑week range extending from a low to a high reflecting significant volatility. The stock has shown higher volatility compared to the broader market. 

The company’s performance has closely tracked industrial demand and raw material price cycles. Positive momentum appeared during the post pandemic recovery, driven by increased demand for agrochemicals and specialty chemicals. However, periods of high raw material costs and competitive pressure from other chemical manufacturers have led to consolidation in the stock price. Profitability has shown variability across recent quarters, with net profit for the quarter ended September 2025 rising 50.98%. 

During the pandemic period, the specialty chemicals sector faced supply chain disruptions. As economic activity normalised and industrial demand recovered, the stock moved from its lows. The company continues to manufacture specialty chemicals for various applications. 

The share price has declined for several recurring reasons. A drop in industrial demand or reduction in chemical realizations directly impacts profitability and leads to selling pressure. Changes in government policy such as modifications in environmental regulations or import duties on raw materials can also cause the stock to fall. Increases in operational costs without matching price adjustments squeeze margins, making the stock less attractive. Periods of global economic slowdown that affect agricultural and industrial sectors raise concerns about demand, leading to price declines. The stock is sensitive to raw material price movements; if acetic acid or chlorine prices rise significantly, it can cause the stock to fall as investors adjust expectations for future margin growth. Broader market sell offs in small‑cap chemical stocks also pull the price down regardless of the company’s individual performance. Lower capacity utilization or reduced sales in any product category directly impacts revenue, resulting in a lower valuation. 

Archit Organosys Limited Investor Relevance and Role in Portfolio 

Archit Organosys Limited is a holding in small‑cap and specialty chemicals sector portfolios, offering exposure to monochloroacetic acid and specialty chemical manufacturing. Its inclusion in chemicals indices underscores its importance in India’s specialty chemical manufacturing space. The company’s position as a manufacturer of MCA, SMCA, and other specialty derivatives, together with its diversified product portfolio, makes it a consideration for certain portfolio allocations. 

The share price is influenced by the company’s ownership structure. Archit Organosys’ equity is held by a mix of promoters, institutional investors, and retail investors, reflecting its standing in India’s specialty chemicals sector. Promoters hold a stable majority stake of approximately 65.88% of the company’s total shares, reflecting strong internal control. Foreign institutional investors hold a certain fraction of the company’s shares. Mutual funds also hold a modest share. The public holds the remaining stake through retail and other individual investors. The company’s management includes Kandarp K Amin as Chairman & Wholetime Director. This investor base, with stable promoter participation, underscores the company’s role as a holding in both domestic and focused portfolios concentrating on specialty chemicals. 

Beyond fundamentals and ownership, the stock is actively monitored in cash market segments, where trading volumes and delivery patterns reflect expectations on industrial demand, raw material costs, and regulatory policy actions affecting the chemical sector. The stock is available for trading on both major Indian exchanges, allowing investors to take positions based on their outlook for the specialty chemicals sector. Market participants watch these trading indicators to gauge sentiment around quarterly results and policy announcements. 

Technical indicators provide additional insight into short‑term momentum shifts in the stock price. While these indicators are primarily used for near‑term trading decisions, they also help investors and portfolio managers understand broader market sentiment and anticipate potential volatility, especially around key events or announcements. In the short‑term and weekly timeframe, the stock has exhibited price movements that correlate with broader chemical sector trends. Based on available data, the company’s P/E ratio is approximately 19.5, which is good value compared to the peer average of 35. The company’s debt to equity ratio reflects a certain use of leverage. Return on equity and return on capital employed are at certain levels, and the company’s book value per share is a reference point for valuation. 

Overall, Archit Organosys demonstrates a higher volatility profile compared to the broader market, with the stock generally considered to have above average systematic risk. This makes it more sensitive to broader market movements and sector‑specific factors such as raw material price fluctuations and industrial demand cycles. 

Archit Organosys Limited Sectoral Relevance and Peer Positioning 

Archit Organosys Limited sector relevance stems from its near‑four‑decade presence in the specialty chemicals industry, its product portfolio covering monochloroacetic acid (MCA), sodium monochloroacetate (SMCA), chloroacetyl chloride, trichloroacetyl chloride (TCAC), organic chemicals, pigments, and specialty derivatives under the AOL brand, its applications in agricultural chemicals, cosmetic surfactants, oil drilling chemicals, plastic additives, and adhesives, its manufacturing operations in Gujarat, and its registered office in Ahmedabad, establishing it as a focused small‑cap specialty chemical provider supporting India’s agriculture, personal care, and industrial ecosystem. Peer comparisons with companies like ARCL Organics Ltd, Balaji Amines Ltd, and other specialty chemical companies focus on production capacity, product quality, export presence, and value‑added product diversification rather than short‑term stock moves. These benchmarks help investors assess operational scale, efficiency, and regulatory adherence. Institutional tracking of raw material prices, industrial demand trends, and government chemical policies further highlights Archit Organosys positioning within India’s broader specialty chemical manufacturing market. 

Archit Organosys P/E ratio reflects how investors perceive the company’s earnings relative to its revenue streams from MCA, SMCA, and other specialty chemical sales. Based on available data, the current P/E ratio stands at approximately 19.5. The company’s profit after tax has shown significant growth, with net profit for the September 2025 quarter rising 50.98%. Quarterly performance has shown variability, with profit after tax increasing from earlier quarters to later quarters, accompanied by growth in total revenue on a quarter‑on‑quarter basis. The company’s earnings before interest and taxes for recent quarters stood at certain levels with corresponding EBIT margins. The net profit margin has improved in recent quarters compared to the same quarters of the prior year. Overall, these changes highlight how market sentiment evolved alongside the company’s operational performance in a cyclical industry. 

Alongside valuation, Archit Organosys earnings per share provide insight into its operational performance and income generation from specialty chemical manufacturing. Based on available data, the company reported a basic EPS in recent quarters that has shown notable improvement. The trailing twelve‑month EPS stands at a certain level. The company’s EPS for the last full fiscal year was higher compared to the prior fiscal year. The company has a specified face value per share. More recent quarterly performance suggests that EPS has shown movement in line with production volumes and raw material costs as the company continues to manage its manufacturing operations. 

Archit Organosys market cap highlights its position as a small‑cap player within India’s specialty chemicals sector. Based on recent data, the company’s market capitalization is approximately ₹96 crore. The market cap has moved in line with investor perceptions of the company’s growth potential as it has expanded its product portfolio. From earlier periods through more recent periods, the market cap showed an increasing trend as the company diversified its chemical offerings, followed by periods of adjustment. This pattern reflects investor confidence during favourable chemical cycles, followed by consolidation during challenging periods impacted by raw material price volatility and economic uncertainties. This movement corresponds with changes in Archit Organosys share price from its annual highs and lows. 

Finally, Archit Organosys earnings trajectory demonstrates the impact of operational execution in a competitive industry. In recent fiscal years, total income showed trends supported by the core chemical business. The company’s revenue from operations has shown variability from one fiscal year to another. Total income has moved across different periods. Profit after tax has shown growth in recent quarters. Quarterly performance has shown variability, with total income in some quarters rising compared to previous quarters and also compared to the same quarters of earlier years. The company has faced headwinds from fluctuating raw material prices, competitive pressures from other chemical manufacturers, and changes in industrial demand. However, the company continues to focus on expanding its product portfolio, maintaining quality standards, and serving its customer base. These developments illustrate the cyclical nature of the specialty chemicals industry and the company’s position within this sector. 

Archit Organosys market cap has moved through different phases corresponding to the company’s performance in specialty chemical manufacturing. The valuation increased during periods of strong industrial demand and stable input costs. The market cap also adjusted during challenging times when raw material costs rose or demand slowed. This pattern reflects typical small‑cap chemical stock behaviour where industrial cycles, input costs and sector conditions influence investor interest. Archit Organosys earnings have shown notable patterns across recent fiscal years, reflecting the company’s performance in the specialty chemical segment. The company recorded a net profit increase in the September 2025 quarter compared to the same quarter of the prior year. This improvement came from increased sales and cost management. Quarterly earnings have shown variability, with some quarters demonstrating stronger performance and others showing moderation. Archit Organosys EPS has followed the company’s overall profit performance across recent periods. The earnings per share figure has shown movement corresponding to profitability changes. Quarterly EPS has shown variation, with some quarters recording positive figures driven by higher sales, and other quarters showing lower numbers. Archit Organosys share price serves as a reference point for understanding the company’s per‑share earnings relative to its market valuation. Archit Organosys P/E ratio has shown variability across different reporting periods, reflecting changing market perceptions of the company’s earnings potential. The price‑to‑earnings multiple has fluctuated based on investor expectations about industrial demand, raw material cost trends and the company’s ability to maintain margins. The P/E level at any given time reflects market sentiment about the company’s recent performance and near‑term prospects in a cyclical industry. 

Summary 

Archit Organosys Limited is a small‑cap specialty chemicals company engaged in manufacturing monochloroacetic acid and other chemical products, headquartered in Ahmedabad. The company was founded in 1989. Archit Organosys share price reflects market response to industrial demand cycles, raw material cost trends and quarterly financial performance. Archit Organosys stock price movements provide insights into how the market views the company’s product portfolio and its positioning within India’s specialty chemical industry. Investors track the company for its presence in the monochloroacetic acid and specialty chemical segment.